• norsk
    • English
  • English 
    • norsk
    • English
  • Login
View Item 
  •   Home
  • Faculty of Medicine
  • Department of Clinical Science
  • Department of Clinical Science
  • View Item
  •   Home
  • Faculty of Medicine
  • Department of Clinical Science
  • Department of Clinical Science
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Glucocorticoid pharmacogenetics in Addison's disease - The role of the immunophilin FK506-binding protein (FKBP51) for glucocorticoid sensitivity

Hynne, Martha Schei
Master thesis
Thumbnail
View/Open
47385780.pdf (1.028Mb)
URI
https://hdl.handle.net/1956/3233
Date
2008-05-31
Metadata
Show full item record
Collections
  • Department of Clinical Science [1078]
Abstract
There is great variation in the inter-individual sensitivity to glucocorticoids. The immunophilin FK506 binding protein (FKBP51) confers short-loop negative feedback inhibition of the glucocorticoid signalling pathway. FKBP51 keeps the human glucocorticoid receptor (hGR)-protein complex in a state of low hormone binding affinity, and will thus inhibit the effect of glucocorticoids. We investigated the role of FKBP51 for the variation in sensitivity to glucocorticoids in patients with primary adrenal insufficiency (Addison's disease). The specific aim of this study was to evaluate the association between the single nucleotide polymorphism (SNP) rs1360780 in the FKBP5 gene encoding FKBP51 and the individual glucocorticoid sensitivity in patients with Addison's disease. Seventeen patients with Addison's disease and 19 controls were genotyped using allelic discrimination assay. In morning blood samples, taken after 18 hours medication fast in the patients, glucocorticoid sensitivity in leukocytes was assessed in an in vitro cell proliferation assay; that is, stimulation with mitogenic lectin phytohemagglutinin (PHA), and incubation with various concentrations of dexamethasone. The FKBP5 expression and the FKBP51 protein levels in leukocytes was determined before and after intravenous infusion of 100 mg hydrocortisone to the patients; using real-time PCR and Western blot analysis respectively. The cell proliferation assay points to increased glucocorticoid sensitivity in Addison's patients associated with the rs1360780 variant T-allele (P=0.001). No such association was found for the controls. The FKBP5 expression, FKBP51 protein levels and ACTH and cortisol levels showed no genotype specific pattern in our study. Increased understanding of the inter-individual glucocorticoid sensitivity and the mechanisms behind may improve treatment with glucocorticoids and increase the knowledge about the pathogenesis of diseases related to glucocorticoid sensitivity, such as depression and metabolic syndrome. Further research is needed to establish the definitive role of FKBP51 and its isoforms, and the the association rs1360780 with glucocorticoid sensitivity.
Publisher
The University of Bergen
Copyright
Copyright the author. All rights reserved
The author

Contact Us | Send Feedback

Privacy policy
DSpace software copyright © 2002-2019  DuraSpace

Service from  Unit
 

 

Browse

ArchiveCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsDocument TypesJournalsThis CollectionBy Issue DateAuthorsTitlesSubjectsDocument TypesJournals

My Account

Login

Statistics

View Usage Statistics

Contact Us | Send Feedback

Privacy policy
DSpace software copyright © 2002-2019  DuraSpace

Service from  Unit